Qu Biologics Launches Phase 2a Clinical Trial for Non-small Cell Lung Cancer (NSCLC)
January 20, 2015 10:00 ET
|
Qu Biologics;BC Cancer Agency
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team
December 04, 2014 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics' Crohn's Disease Clinical Trial Completes Independent Safety Review
October 29, 2014 09:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 29, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Closes Oversubscribed Private Funding Round of CDN$5.1 Million
September 17, 2014 10:05 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Appoints Dr. Bob Cory as Vice President, Business Development
June 17, 2014 10:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived from Viruses for Treating a Range of Cancers
June 04, 2014 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Colon Cancer
May 20, 2014 13:07 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference
April 28, 2014 14:45 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants
February 20, 2014 20:49 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants
February 18, 2014 09:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...